These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18680692)

  • 1. [Toxicogenetics of antiretroviral treatment (1): lipodystrophy, metabolic perturbations and atherosclerosis].
    Gutiérrez Maciá MM; Mateo García MG; Vidal Marsal F; Domingo Pedrol P
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():18-23. PubMed ID: 18680692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.
    Veloso S; Peraire J; Viladés C; López-Dupla M; Escoté X; Olona M; Garcia-Pardo G; Gómez-Bertomeu F; Soriano A; Sirvent JJ; Vidal F
    Curr Pharm Des; 2010 Oct; 16(30):3379-89. PubMed ID: 20687887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.
    Tarr PE; Telenti A
    Antivir Ther; 2007; 12(7):999-1013. PubMed ID: 18018758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.
    Bonnet E; Genoux A; Bernard J; Fauvel J; Massip P; Perret B
    Clin Chem Lab Med; 2007; 45(7):815-21. PubMed ID: 17617020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy.
    Escoté X; Megia A; López-Dupla M; Miranda M; Veloso S; Alba V; Domingo P; Pardo P; Viladés C; Peraire J; Giralt M; Richart C; Vendrell J; Vidal F;
    HIV Med; 2011 Aug; 12(7):428-37. PubMed ID: 21251185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
    Fantoni M; Del Borgo C; Autore C; Barbaro G
    Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.
    Villarroya F; Domingo P; Giralt M
    Biochim Biophys Acta; 2010 Mar; 1801(3):392-9. PubMed ID: 19800025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.
    Maher B; Alfirevic A; Vilar FJ; Wilkins EG; Park BK; Pirmohamed M
    AIDS; 2002 Oct; 16(15):2013-8. PubMed ID: 12370499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism.
    Mahajan SD; Gaekwad A; Pawar J; Tripathy S; Ghate M; Bhattacharya J; Singh HO; Schwartz SA; Paranjape R; Gangakhedkar R
    Curr HIV Res; 2015; 13(2):98-108. PubMed ID: 25439236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy.
    Kannisto K; Sutinen J; Korsheninnikova E; Fisher RM; Ehrenborg E; Gertow K; Virkamäki A; Nyman T; Vidal H; Hamsten A; Yki-Järvinen H
    AIDS; 2003 Aug; 17(12):1753-62. PubMed ID: 12891061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.
    Peraire J; López-Dupla M; Alba V; Beltrán-Debón R; Martinez E; Domingo P; Asensi V; Leal M; Viladés C; Inza MI; Escoté X; Arnedo M; Mateo G; Valle-Garay E; Ferrando-Martinez S; Veloso S; Vendrell J; Gatell JM; Vidal F;
    Clin Microbiol Infect; 2015 Jul; 21(7):711.e1-8. PubMed ID: 25882366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxicogenetics of antiretroviral treatment (II): neurotoxicity, hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects of antiretroviral drugs].
    Sánchez Hellín V; Gutiérrez Rodero F
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():24-33. PubMed ID: 18680693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
    Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
    Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.
    Hulgan T; Tebas P; Canter JA; Mulligan K; Haas DW; Dubé M; Grinspoon S; Robbins GK; Motsinger AA; Kallianpur AR;
    J Infect Dis; 2008 Mar; 197(6):858-66. PubMed ID: 18419350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs.
    Ceperuelo-Mallafré V; Escoté X; Viladés C; Peraire J; Domingo P; Solano E; Sirvent JJ; Pastor R; Tinahones F; Leal M; Richart C; Vendrell J; Vidal F; ; Alba V; Aguilar A; Auguet T; Chacón MR; López-Dupla M; Megia A; Miranda M; Olona M; Saurí A; Vargas M; Velasco I; Veloso S; Fontanet A; Gutiérrez M; Mateo G; Muñoz J; Sambeat MA
    HIV Med; 2012 May; 13(5):297-303. PubMed ID: 22256965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.